NCT00407862View on ClinicalTrials.gov

Telmisartan and Losartan in Hypertensive IGT

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

June 30, 2006

Conditions
HypertensionImpaired Glucose Tolerance
Interventions
DRUG

Telmisartan 80 mg

DRUG

Losartan 50 mg

Trial Locations (1)

8036

Medical University of Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT00407862 - Telmisartan and Losartan in Hypertensive IGT | Biotech Hunter | Biotech Hunter